Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial public offering in the United States, according to a regulatory filing.

The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking to raise as much as $157.5 million in its initial public offering and a private placement.

Schloss Bangalore, parent company of the Leela Hotels, has filed for a $599 million IPO, the largest ever in India's hotel industry.

Schloss Bangalore, owner of Indian luxury hotel chain 'The Leela', has filed for a 50 billion rupee ($599 million) IPO on Friday, aiming to cash in on the country's red-hot stock market.

Schloss Bangalore, parent of The Leela hotel chain, has filed DHRP for a ₹5,000 crore IPO, intending to raise ₹3,000 crore through new shares and ₹2,000 crore via an offer for sale